Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients.

Damir VucinicIva SkocilicMarin GolcicRenata Dobrila-DintinjanaMaja KolakIvona JerkovicEleonora Cini TesarAni Mihaljevic FerariArnela RedjovicJasna MarusicDoris KolovratIvana Mikolasevic

Published in: Journal of personalized medicine (2024)

The effectiveness of ICIs in older cancer patients primarily depends on the line of treatment and treatment discontinuation. Octogenarians experienced similar treatment responses, PFS, OS, and adverse effects compared to septuagenarians.

Keyphrases

randomized controlled trial
systematic review
physical activity
middle aged
community dwelling